January 17, 2018 / 9:30 PM / 10 months ago

BRIEF-Amgen says Analysis From Kyprolis Trial Published in Journal Of Clinical Oncology

1 Min Read

Jan 17 (Reuters) - Amgen Inc:

* OVERALL SURVIVAL ANALYSIS FROM KYPROLIS® (CARFILZOMIB) PHASE 3 ASPIRE TRIAL PUBLISHED IN THE JOURNAL OF CLINICAL ONCOLOGY Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.

0 : 0

narrow-browser-and-phone
medium-browser-and-portrait-tablet
landscape-tablet
medium-wide-browser
wide-browser-and-larger
medium-browser-and-landscape-tablet
medium-wide-browser-and-larger
above-phone
portrait-tablet-and-above
above-portrait-tablet
landscape-tablet-and-above
landscape-tablet-and-medium-wide-browser
portrait-tablet-and-below
landscape-tablet-and-below